EPDR1 inhibits TRIM21/NF-κB interaction, stabilizes NF-κB-mediated transcriptional upregulation of PD-L1 in hepatocellular carcinoma cells, and inhibits immune response [189]. Here, NFKB1 is linked to hepatocellular carcinoma.